Inhibikase Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.03

+0.10 (+5.18%)

As of Jun 30, 10:25 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +1,279.8% upside

Low Target $19.41

Average Target $28.01

High Target $39.32

Current Price $2.03

Current
$2.03

Target
$28.01

$19.41 $28.01 avg $39.32

Scenario Analysis

Bear Case

$19.41

856.2%

Low target

Base Case

$28.01

+1,279.8%

Avg target

Bull Case

$39.32

+1,836.9%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$2.26

-10.2% from high

52-Week Low

$1.33

+52.6% from low

Target vs 52W High

$28.01

+1,139.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%